BRIEF-Antares Pharma says received FDA letter regarding deficiencies of its drug Xyosted
October 12, 2017 at 17:08 PM EDT
* Antares Pharma Inc - anticipate receiving further clarification from FDA on or before prescription drug user fee act (PDUFA) date of October 20, 2017
